Washington University School of Medicine: Multiple Sclerosis trials

The registry lists 11 Multiple Sclerosis studies with Washington University School of Medicine as lead sponsor. 3 are open to participants now and 1 have results posted.

Phase 2 1Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.RecruitingNCT07758270
• This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.RecruitingNCT07115017
• Smoldering Inflammation in MSRecruitingNCT06591429
• Ampyra for Optic Neuritis in Multiple SclerosisCompletedNCT01337986Phase 2/3Results posted
• Gut Microbiome and DepressionTerminatedNCT05808101
• Adapting MHealth Technology to Improve Patient ActivationCompletedNCT04893590Not applicable
• SPINCOMS Biomarker StudyCompletedNCT04496830
• A Wheelchair Propulsion Training ProgramCompletedNCT04009187Not applicable
• Intermittent Fasting in Multiple SclerosisCompletedNCT03539094Not applicable
• Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MSWithdrawnNCT02675413Phase 4
• Calorie Restriction in Multiple Sclerosis PatientsCompletedNCT02411838Not applicable